GSK boasts a deep portfolio of marketed and investigational respiratory products, which can treat asthma patients with high levels of eosinophils or high T2 inflammation.

GSK hosted the third annual RespiVerse meeting on December 13-14 in Bangkok, Thailand, bringing together renowned ...

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together ...

GlaxoSmithKline's pitch to shareholders kicked off this afternoon with an optimistic view of its late-stage pipeline – including some big sales predictions for products like its respiratory ...

By collaborating with top-level specialist physicians and highly qualified experts from around the world, GSK has developed a world-class program to achieve excellence in clinical practices and ...

Revised deal with Zhifei to manage near-term challenges GSK shares marginally lower Potential RSV collaboration for initial 10-year term Dec 5 (Reuters) - China's Zhifei (300122.SZ), opens new tab ...

Gur Levy, Respiratory Medical Expert at GSK, said, "We have been pioneering ... targeted biological products, and inhaled medicines at the forefront of the respiratory sector, aiming to improve ...